📰 Epigenetic Reprogramming News
Epigenetic Reprogramming News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Epigenetic Reprogramming. Real-time updates on events, politics, business and more.
May 28, 2024
MOUNTAIN VIEW, Calif., May 28, 2024 /PRNewswire/ -- Turn Biotechnologies, a developer of novel mRNA medicines and enabling technologies, today announced an
May 28, 2024
Synergistic collaboration to revolutionize age-related therapies worldwideDeal valued at over $300 million USD for initial product MOUNTAIN VIEW, Calif., May 28, 2024 /PRNewswire/ -- Turn Biotechnologies
November 4, 2023
Phase 1 Trial of LYL797, a ROR1-Targeted CAR T-Cell Therapy Enhanced With Genetic and Epigenetic Reprogramming, in Advanced Triple-Negative...
September 5, 2023
Day four out of five of the 10th ARDD was full of new revelations. For example we learned that that median lifespan of taurine-treated mice increased by 10 to 12%!
May 9, 2023
/PRNewswire/ -- Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines for untreatable, age-related conditions, today announced that...
April 13, 2023
/PRNewswire/ -- Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines for untreatable, age-related conditions, announced the...
April 4, 2023
/PRNewswire/ -- Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines to cure untreatable, age-related conditions, today announced...
March 30, 2023
MOUNTAIN VIEW, Calif., March 30, 2023 /PRNewswire/ -- Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines to cure untreatable, age-related conditions, announced
February 28, 2023
/PRNewswire/ -- Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines to cure untreatable, age-related conditions, today will...